National Jewish Health Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2011
NCT01651442
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

National Jewish Health: Division of Pediatric Allergy and Clinical Immunology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

Problem Behavior (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5